HopeStage
Back to all studies
Not Yet RecruitingNCT07671248

Tirzepatide in the Treatment of Addiction

Medication studyAges 18+Canada
The study in practice

Understand this study

Who could participate?

Listed age limits: from 18 years.

Listed locations
HamiltonSee all locations and recruitment
Study phase
Phase 3Usually a larger study designed to confirm effectiveness and safety in a broader group.

Get this study by email

HopeStage may email me about this study.
Loading the security check...

What to know before participating

A point to clarify

This summary does not cover all risks or eligibility requirements. What risks or changes to my care would apply to me?

Study clarity

Things to check before joining

Study start dateEstimated: August 1, 2026
Recruitment status
Not Yet Recruiting
Enrollment listed in the registry
15
Sponsor
McMaster University
Sponsor type
University
Study type
Drug
Intervention type
Drug
Study phase
Phase 3Usually a larger study designed to confirm effectiveness and safety in a broader group.
Locations
Canada
Age range
Over 18 Years
Official registry ID
NCT07671248
Official title
Show the full official title

A 12-Week Phase 3 Clinical Trial to Evaluate the Safety, Tolerability and Efficacy of Tirzepatide-Assisted-Psychotherapy in Adults With Cannabis Use Disorder: A Proof-of-Concept Study

Recruitment & locations

Not yet recruiting

Hamilton

Interested in joining this study?

HopeStage may email me about this study.
Loading the security check...
FAQ

Questions about this study

Who is behind this study?

The study sponsor is McMaster University, a university.

Does this study involve medication?

Yes. The study involves medication, including Tirzepatide.

Who can participate?

Listed age limits: from 18 years.

Is this study still recruiting?

The registry lists this study as not yet recruiting.

Want to explore more studies?

Explore studies